Mad Money
Amarin Charts Are Charting a Course Toward Improvement
However, traders will need to show a lot of patience if they buy shares of the biopharmaceutical company.
Are the Odds in Your Favor Now With Wynn Resorts?
Let's check out the charts of WYNN again to see if the worst is behind us.
Why Biopharmaceutical Dynavax Technologies Could Soar in 2022
Here's how traders can play the stock.
Gilat Satellite Networks Is Cheap but the Charts Don't Say Buy
The stock price may be cheap but it could get even cheaper.
Ulta Beauty's Charts Are Looking Pretty
Here's our latest strategy and price target.
Unity Software Looks Poised to Rally Into Year-End
Jim Cramer said the 3D market is owned by Unity.
Standard Lithium Could Power Its Way to New Heights
However, the lithium play is speculative, so traders would do well to recognize the risk before acting.
IBM Gets a Nod From Larry Williams; Here's What My Charts Say
Let's see where traders could approach the long side of IBM.
Uber's Sharp Rebound Strains Our Analysis Techniques
Hop in or wait for another ride?
Pitney Bowes Is Still Looking Bearish
Here's what the charts and indicators tell me about PBI stock.